Hepatology 2007: Vol 45 Index

2007·14.3 MB·English

INDEXES
Author Index to Volume 45*
A Alphonse MP (see Aborsangaya KB et al).
2007 :45:623-630
Abdelnour M (see Louvet Ae t al). 2007:45 Alsié A (see Westin] ). 2007:45:1 Back Madruga C (see Fontana RJ et al
1348-1354 (Correspondence) 2007;45:1154-1163
Abe H ee Hatakeyama | et il 2007:45 Amigo | (see Castro J et al). 2007:45:1261 Bader M (see Nocito Ae t al). 2007:45:369
1179-1186 1266 376
Abergel A (see Nousbaum JB et al). 2007 Ananthanarayanan M Cherapy for Baftet G (see Frémin C et al). 2007;45
+5:1275-1281 hepatocyte transporter trafficking 1035-1045
Abiru S (see Nakamura M et al). 2007;45 mutations: The time is now. 2007;45 Bajaj JS, Etremadian A, Hafeezullah M
118-127 1340-1342 ] Editorial) Saeian K. Testing for minimal hepatic
Aborsangaya KB, Dembinski I, Khatkar S Anderson KE. Porphyria cutanea tarda: A encephalopathy in the United States
Alphonse MP, Nickerson P, Rempel
possible role for ascorbic acid. 2007 An AASLD Survey. 2007;45:833-834
jD. Impact of aboriginal ethnicity on
+5:6-8 (Editorial Correspondence)
HCV core-induced IL-10 synthesis
Anderson V (see Hussain N et al). 2007;45 Balabaud C (see Boyault S et al). 2007;45
Interaction with IL-10 gene
675-683 42-52
polymorphisms 2007-45:62 3-630 Andreone P (see BrunSo e t al). 2007;45 Balestra D (see Gorman N et al). 2007;45
Abramovitch R (see Ben Moshe T et al
579 587 187-194
2007:45:1014-1024
Angeli P (see Fasolato Se t al). 2007;45 Balistreri WF and Bologna G. An editor for
Acute Liver Failure Study Group (se. 123-229
all seasons: The “impact” of Dr
Parekh NK et al). 2007:45:1489-1495
Adachi H (see Nakamura M et al). 2007 Angulo P, Hui JM, Marchesini G Andres Blei. 2007;45:261-262
Bugianesi E, George J, FarrellG C (Editorial
$5:118-127
Enders F, Saksena S, Burt AD, Bida Balistreri WI ee Perlmutter DH et al)
AdamsDH (see Lalor PF et al). 2007;45
JP, Lindor K, Sanderson SO, Lenzi 2007;45:1313-1323 (Review)
465-474
M, Adams LA, Kench J, Therneau Barash H (see Ben Moshe T et al). 200
Adams LA (see Angulo Pe t al). 2007:45
lM, Day CP. The NAFLD fibrosis #5:1014-1024
846-854
\dams VA (see Rollie S et al). 2007:45 score: A noninvasive system that Barbier O and Trottier J]. Why bile acid
602 613 identifies liver fibrosis in patients with glucuronidation is a minor pathway
NAFLD. 2007;45:846-854 for conjugation of endogenous bile
fdhal N € Pockros P] et al 2007 +5
569-578 Ansari AA Moritoki Y et al). 200 acRiedpsl y in man. 2007;45:1084-1085
Afdhal NH (see Conj varaHSm etal 314-322
2007:45:80-87 see Oertelt S et al). 2007:45:659-665 Barchowsky A (see Straub AC et al). 2007
ee Goodman ZD et al). 2007;45:886 Antoniotti P (see Bordoni V et al). 200 $5:205-212
894 45:1218 2} ce Parente F et al). 2007;45
Anzai N (see Shin al). 2007;45:1046
\garwal R ‘ t al). 2007:45
549-559 1055 BarosiG (see Primignani M et al). 2007;45
Aparicio E (see Franc et al). 2007:45
Ahlawat S (see Hussain N et al). 200
675-683 899-910 Barsky L (see Rountree CB et al). 2007;45
Aimitsu S (see Hatakeyama T et al). 200 \ pte [ see Zeng Ge t il). 2007:45:195 1250-1260
+5:1179-1186 204 Bartosch B (see Rollier CS et al). 2007;45
Aisaka Y (see Hatakeyama T et al). 2007; Arbuthnot P (see Lian Z et al). 2007;45 602-613
+5:1179-1186 1390-1 3¢ Barua | see Gkretsi V et al). 2007;45
Akhurst B (see YeohG C et al). 2007:45 Ardizzonz e S$ : F eta l). 2007;45 1025-1034
#80-494 1267-12 Barve S (see McClain C]e t al). 2007:45
Akisaw iN Ce Hirose A et il 2007-45 Arena U (see Vizzutti F et al). 200 1343-1346 (Editorial)
1375-138] 1290-1297
Beaulieu S (see Nousbaum JB et al). 2007
il Hawajri N (see Le Gal F et al). 2007;45 Ascione A (see BrunSo e t al). 2007:45:579 $5:1275-1281
1332-1333 (Reply 587 Becker G, Allgaier HP, Olschewski M,
Alegret M (see Roglans N 2007 Assenat E (see Pascussi JM et al). 2007;45 Zahringer A, Blum HE. Long-acting
778-788 1146-1153 octreotide versus placebo for
Alexander W (see YeohG CT et al). 2007 Association Nationale des Hépato treatment of advanced HCC: A
t9:450-494 Gastroentérologues des Hépitaux randomized controlled double-blind
Allgaier HP (see Becker et al). 2007;45:9 Généraux de France (see Nousbaum study. 2007;45:9-15
15 JBe t al). 2007;45:1275-1281 Becker RL Jr (see Goodman ZD et al)
AlmasioP l ee BrunSo e t al). 2007:45 Audigier JC (see Nousbaum JB et al). 2007 2007;45:886-894
579-587 $5:1275-1281 Bélanger A (see Bonzo JA et al). 2007;45
Alonzi T (see Bordoni V et al). 2007;45 Awan F (see ZenGg e t al). 2007;45:195 349-360
1218-1228 204 Belghiti J (see Boyault S et al). 2007;45:42
52
Bell AW (see Paranjpe Se t al). 2007;45
1471-1477
1-260; Februa Belli G (see Vizzutti F et al). 2007;45:1290
] 97
AUTHOR INDEX HEPATOLOGY, June 200
Iza I (see Marqués JM et al). 2007;45 Bjdrnsson E, Chari ST, Smyrk TC, Lindor Brooks HF (see WrighGt e t al). 2007;45
1517-1526
639-648 K. Immunoglobulin G4 associated
Moshe T, Barash H, Kang TB, Kim cholangitis Description of an Bruix J Wurmbach E et al). 2007;45
IC, Kovalenko A, Gross | emerging clinical entity based on 938-947
Schuchmann M, Abramovitch R view of the literature. 2007;45 Bruno S, Stroftolini T, Colombo M
Galun E, Wallach D. Rol 947-1554 (Review llani S, Benvegnt: L, Mazzella G
8 in hepatocyte response see Pascussi ]M et al). 2007:45 Ascione A, Santantonio |, Piccinino
ind injury in mice. 200 1146-1153 F, Andreone P, Mangia A, GaetaG B
Blatt LM (see Pockros P] et al). 2007;45 Persico M, Fagiuoli S, Almasio PI
ee Bertolino Pe t 569-578 Sust 1ined virological response to
1580-1582 Hepatolog Blum HI (see Becker et al). 2007:45:9-15 interteron-a@ is associated with
egnti | ee BrunSo e t Boelsterli UA (see Latchoumycandane ¢ improved outcome in HCV-related
579.587 il). 2007;45:412-421 cirrhosis \ retrospective study. 2007
za N and Traurwein C. Restoration of Boedanos DP, Liaskos ¢ Pares vorman $5:5/9-58
p53 function: A new therapeutic G, Rigopoulou EI, Caballeria I Bucciarelli P (see Primignani M et al
2007 ;45:832-833 (Reply
strategy to induce tumor regression Dalekos GN, Rodes J, Vergani D
2007;45:1578-1579 (Hepatology Budinger GRS (see Subramanian RM et al
Anti-gp210 antibody mirrors disease
2007:45:455-464
I lewhere severity in primary biliary cirrhosis
Berg T (see Schmécker C et al). 200 2007:45:1583 (¢€ orrespondence Bugianesi E (see Angulo Pe t al). 2007;45
864-5609 Boisselier P (see Frémin C et al). 2007;45 540-554
BergamaschiG (see Primignani M et al Bull | (see Jeftrey GP et al). 2007:45:111
1035-1045
2007-45:8 32-833
Berland JI ee Rollier CS « 1). 2007;45 Bolesla1w3s4k8i- 1|3 54 see Louvet Ae t al). 2007;45 Bureau5 :¢1 275ee- 1N2o8u1 sbaum JB et al). 200
602-613
Bollani S (see Bruno S et al). 2007;45:579
Bernard PH (see Nousbaum JB et al Burt AD (see AnguPl eot al). 2007;45:846
587
2007;45:1275-1281 854
Bonzo JA, Bélanger A, Tukey RH. The role
Bertolini F (see Bordoni V et al). 2007;45 ee Robertson H et al). 2007;45:977
1218-1228 of chrysin and the Ah receptor in 98]
induction of the human UGT/A/
Bertolino P, Bowen DG, Benseler V. 1 Burt JA (see Newton JL et al). 2007:45
gene in vitro and in transgenic UGT]
1496-1505
cells in the liver Chere is life beyond mice. 2007;45:349-360
the graveyard. 2007;45:1580-1582 Bustos M €t Marques IM et il 2007:45
Boo | (see Torresi | et al). 2007;45:91 1-920 639-648
Hepatology I lsewhere Bordoni V, Alonzi T, Zanetta L, Khouri Butler SD (see Menne Se t al). 2007;45
Bertolino P and Holz LE. Toll-like
D, Conti A, Corazzari M, Bertolini I
receptor-3 and the regulation of 614-622
intrahepatic immunity: Implications Antoniotti P, Pisani G, Tognoli I Byun KS (see Yoo BC et al). 2007;45:11
for interferon-alpha therapy. 2007;45 Dejana E, Tripodi M. Hepatocyte 1178
conditioned medium sustains
250-251 Hepatology Elsewhere
Bertolotti M (see Lonardo A et al). 200 ehnedmoatthoeploiiael tidci-fefnedroentthiealtiiaoln of human c
+) 25 Correspondence
progenitors. 2007;45:1218-1228
Bessard A (see Frémin C et al). 2007;45
Bortolotti F and Guido M. Hepatitis B in Caballeria L (see Bogdanos DP et al). 2007
1035-1045 children. 2007;45:831 +5:1583 (Correspondence)
Besse 1P6 7.(s7ee 77M artin PGP et al). 2007;45 Correspondence Cadranel JF (see Nousbaum JB et al). 2007
$5:1275-1281
Bevans S (see Savransky V et al). 2007;45 Bosca 63L8 (see Casado M et al). 2007:45:631 ee Thévenot T et al). 2007;45:377
1007-1013 83
Bhanot S (see Yamaguchi K et al). 2007;45 Bottinger E (see Wurmbach E et al). 2007; Cai J, ZhaoY , Liu Y, Ye F, Song Z, Qin
1366-1374 $5:938-947 H, MengS , ¢ hen Y, Zhou R Song
Bhave VS (see Donthamsetty S et al). 2007 Bowen DG (see Bertolino P et al). 2007:45 X, Guo Y, Ding M, Deng H
$5:391-403 1580-1582 (Hepatology Elsewhere Directed differentiation of human
Bian H] (see Xu J et al). 2007;45:269-276 Bowen W( see Gkretsi V et al). 2007:45 embryonic stem cells into functional
Biburger M (see Erhardt Ae t al). 2007;45 1025-1034
hepatic cells. 2007;45:1229-1239
175-485 ee Paranjpe S et al). 2007;45:1471
umpbell JS (see Nguyen LN et al
Bida 8J5P4 (see Angulo Pe t al). 2007:45:846 Boyaul1t4 77S, Rickman DS, de Reyniés A +5:31-41
ampello C (see Pollicino T et al). 2007
Biecker E (see HennenbeM regt a l). 2007 Balabaud C, Rebouissou S, Jeannot I 4$5:277-285
$5:495-506 Hérault A, Saric J, Belghiti J, Franco
anva V (see Louvet A et al) 2007-45
Bieliauskas LA (see Fontana RJ et al). 2007 D, Bioulac-Sage P, Laurent-Puig P 1348-1354
45:1154-1163 Zucman-Rossi J. Transcriptome arey MC (see WangHH et al). 2007;45
Bioulac-Sage P (see Boyault S et al). 2007 classification of HCC is related to 998-1006 ,
45:42-5 , gene alterations and to new urtier-Ugarte D (see Fernandez V et al
ee Pascussi JM et al). 2007;45:1146 therapeutic targets. 2007;45:42-52 2007:45:170-177
1153 Braden B (see Dietrich CF et al). 2007;45 arulli N (see Lonardo Ae t al). 2007;45
Bisgaard HC (see Jelnes Pe t al). 2007;45 1139-1145 257 (Correspondence)
1462-1470 Brodsky JL (see Perlmutter DH et al) arvalho Filho RJ (see Schiavon LL et al).
Bissell DM (see Friedman SL et al). 2007; 2007;45:1313-1323 (Review) 2007;45:257-258 (Correspondence)
45:242-249 (AASLD Single Topic Bronowicki JP (see Nousbaum JB et al) asado M, Molla B, Roy R, Fernandez
Conference 2007;45:1275-1281 Martinez A, Cucarella C, Mayoral R,
HEPATOLOGY, Vol. 45, No F AUTHOR INDEX
Bosca L, Martin-Sanz P. Protection hang J (see Visvanathan K et al). 2007;45 hung RT (see O'Leary JG et al). 2007:45:
against Fas-induced liver apoptosis in 102-110 895-898
transgenic mice expressing hari ST (see Bjérnsson E et al). 2007:45 hung YH (see Yoo BC et al). 2007;45
cyclooxygenase-2 in hepatocytes 1547-1554 (Review 1172-1178
2007;45:63 1-638 haudhry UI (see Kingham TP et al) illo U (see FasolatSo e t al). 2007:45:223
ussader M (see Gambino R et al). 2007 2007;45:445-454 229
+5:1097-1107 hawlaYK (see PrasSa edt al). 2007:45 lavien PA (see El-Badry AMet al). 2007
Ineau ¢ é ¢ ‘ et al). 2007:4 549-559 +5:855-863
332-1333 Reply havama K (see Hatakeyama $ ee Nocito A et al 2007:45:369-376
astillo | (see Fernandez V et 2007:45 2007:45:1179-1186 lemensD L (see Osna NA et al). 2007:45
0-177 hen DS (see Lin CL et al s 53-61
stro J, Amigo L, Miquel JF, Galman ¢ 1198 lément S (see Pazienza V et al). 2007
Crovari F, Raddatz A, Zanlungo S ee Su TH etal). 2007;45:1586-1587 1164-1171
Jalil R, Rudling M, Nervi F. Increased Correspondence lotet B (see FranSc eot al). 2007;45:899
activity of hepatic microsomal hen PJ (see Lin CL et al). 2007:45:1193 910
triglyceride transfer protein and bil 1198 lub Francophone pour !’Etude de
icid synthesis in gallstone disease hen W (see ZhengY et al). 2007:45:16 Hype rtension Portale (see Nousbaum
007:45:1261-1266 2] JB et al). 2007;45:1275-1281
Causse X (see Thévenot T et al). 2007;45 hen XG (see Xu J et al). 2007;45:269-276 olagrande S (see Vizzutti F et al). 2007
377-383 hen Y, Yang Y, Miller ML, Shen D #5:1290-1297
Cederbaum Al (see Dey A and Cederbaum Shertzer HG, Stringer KF, Wang B olecchia A and Festi D. Biliary
AI). 2007:45:1355-1365 Scleestdion SM Wilco TY, Dicken symptoms, gallbladder motility, and
Cerec V, Glaise D, Garnier D, Morosan S rP Hepatocyt« specific Gelc deletion cholecystectomy. 2007;45:259-260
lurlin B,’ Drenou B, Gripon P l' eads to rapid ' onset of steatosis with ( orrespondence )
Kremsdorf D, Guguen-Guillouzo ¢ mitochondrial injury and liver failure olombo M (see Bruno S et al). 2007:45
Corlu ransdifterentiation of 2007;45:1118-1128 579-587
hepatocyte-like cells from the human en e Cai J et al). 2007;45:1229 omella JX (see Moumen A et al). 2007;
45:1210-1217
hepatoma HepaRG cell 1] line through 123 4)
: ompany L (see Romero-Gémez M et al)
bipotent progenitor. 2007;45 957 ee Wurmbach E et al). 2007:45:938
2007 ;45:879-885
967 94
onjeevaram HS, Kleiner DE, Everhart JE,
vagneau-Derrode C (see Nousbaum JB et n YH (see Chang C] et al). 2007:45
Hoofnagle JH, Zacks S$, Afdhal NH
il). 2007;45:1275-1281 .
Wahed AS. Race, insulin resistance
ilasaniN (see Imperiale TF et al). 2007 heZNn ( see Xu J et al). 2007:45:269-276
and hepatic steatosis in chronic
+5:870-878 heng HW (see Chang C] et al). 2007:45
hepatitis C. 2007;45:80-87
in Al ee Yeo W eral 5 382 746-754 ontaldo C (see El-Badry AM et al). 2007;
1389 eng ee YinH eral
45:855-863
han CY (see Wong CM et al). 2007;45
onti A (see BordoniV et al). 2007:45
1129-1138
1218-1228
in EP and Wells RG. Today’s hepatic 5:112
onway I (see Grebely | et al). 2007345
stellate cells: Not your father’s hing YP (see Wong CM et al). 2007:45 oe >
ternzellen. 2007;45:1326-1327 1129-1138 1331 (Reply
onzelman S (see Pazienza V et al). 2007;
Hepatology I sewhere hiusolo P S€¢ De Stefano V et al 2007 +5:1164-1171
in JL (see O'Leary JG eta l). 2007;45 #5:831-832 (¢ orrespondence oppel RL (see Moritoki Y et al). 2007;45:
895-898 ho M (see Yoo BC et al). 2007:45:1172
314-3 ”
hvaan n PPKK S ee Yeo W etal).il ). 2200 07:45+ 1ii1 78 ee Ocrtelt S et al) 20077.: 45A:S6L5 9-665 <
1309.13.99 eae 17-45-1179
oa nee no SH ¢ Yoo BC et al). 2007;45:1172 orazzari M (see Bordoni V et al). 200
han SF (see Chang C] et al). 2007;45 1178 #5:1218-1228
746-754 hoi TY (see Yoo BC et a 2007:45:1172 érdoba | (see Romero-Gémez M et al)
ian SI ee Yeo W et al). 2007:45:1382 1: 178 2007 :45:879-885
1589 hoi SK (see Yoo BC et al). 2007;45:1172 orlu A (see Cerec V et al). 2007;45:957
hand N and Sanyal A] Sepsis induced 1178 967
cholestasis. 2007:45:230-241 hon CY (see Yoo BC et al). 2007;45 ortés V and Rigorti A. Liver heparan
Review 1172-1178 sulfate proteoglycans: Old molecules
handel N (see Subramanian RM et al hoyke P (see Hussain N et al). 2007;45 provide new insightosn lipoprotein
2007;45:455-464 675-683 metabolism. 2007;45:1078-1080
hang CJ, Chen YH, Huang KW, Cheng hu CM and Liaw YF. HBsAg (Hepatology Elsewhere)
HW, Chan SF, Tai KF, Hwang LH seroclearance in asymptomatic carriers osset FI (see Rollier CS et al). 2007:45
Combined GM-CSF and IL-12 gene of high endemic areas: Appreciably 602-613
therapy synergistically suppresses the high rates during a long-term follow ostantino L (see Pollicino T et al). 2007:
2rowth of orthotopic liver tumors up. 2007;45:1187 1192 45:277-285
2007 :45:746-754 rua | et Jettrey GP et al 2007:45:111 ote PI (see Menne S et al). 2007:45:614
Chang CP, YangM C, Liu HS, Lin YS, Lei 117 622
HY. Concanavalin A induces ang WL (see Yu ML et al). 2007;45 Crippin JS. Treatment of hepatocellular
autophagy in hepatoma cells and has a 1587-1588 (Reply carcinoma after transplantation and
therapeutic effect in a murine in situ ang YH (see Moritoki Y et al). 2007; human rights. 2007;45:263-265
hepatoma model. 2007;45:286-296 45:314-3>2 2 (Editorial)
AUTHOR INDEX HEPATOLOGY, June 2007
( rispe IN (see John B et al Déjean S (see Martin PGP et al). 2007:45 Diepolder HM (see Rollier CS et al). 2007
167.997
186 +5:602-613
Croker B (see Yeoh GC Dejong CHC (see Olde Damink SWM Dietrich CF, Mertens JC, Braden B,
4180-494 2007:45:560-568 Schuessler G, Ort M, Ignee A
( rooks GM ee Rountree Dekhtyar T (see Ng TI et al). 2007;45 Contrast-enhanced ultrasound of
45:1250-1260 1413-142] histologically proven liver
rovari | ee ( astro | et il). 200 +) del Olmo JA (see Romero-Gémez M et al hemangiomas. 2007;45:1139-1145
1192 61 , 66 2007:45:879-885 Dimou | ee Rapti I et al)|. 2007;45:307
ucarella ¢ ee CasadoM et al). 2007:45 Dell’Era A (see Primignani M et al). 2007 4 13
631-638 45:832.- 833 (Reply DingM (see Cai J et a 2007;45:1229
ucino ( ee Parente F et al). 2007:45 Deltenre P( see Louvet Ae t al). 2007345 1239
1267-1274 ymbrowski F and Evert M. Revelation of
ui W ee Liu JL and Cui W 2007-45 DeMatteoRP (see Kingham TP et al simple and complex liver acini after
1584-1585 (¢ orrespondence 2007:45:445-454 portal transplantation of pancreatic
Dembinski | (see Aborsangaya KB et al islets or thyroid follicles in rats. 2007
2007;45:62 3-630 $5:705-715
Demetris A] (see ZenG egt a l). 2007:45 yna S (see Fasolato S et al). 2007
195-204 99
Dabeva MI YovchMIe evt al
2007:45:1229 yng Z, Zhang J, Sun R, Wei H, Tian Z
>) 39.149 Impairment of liver regeneration
Dahm | Nocito Ae t DengQ (see Malmassari SL et al). 2007;45 correlates with activated hepatic NK]
1199-1209 cells in HBV transgenic mice. 2007
Dai 15CY 88 (Reply Denis | S€e Thévenot | et il 2007:45 1400-1412
yno R (see Moumen A et al). 2007:45
377-383
likoku M ee Nak imufa DennisL B (see Grace ND and DennisL B 1210-1217
15:118-12 2007;45:1337-1339 (AASLD Public ynohue TM Ir (see Osna NA et al). 2007
ilekos GN et Bogdanos Policy 15:53-6]1
2007:45:1583
onthamsetty S, Bhave VS, Mitra MS
Dény P( see Le Gal F et al). 2007;45:1332
Latendresse JR, Mehendale HM
Desmond P (see Visvanathan Ke t al Nonalcoholic fatty liver sensitizes rats
tor RN to carbon tetrachloride hepatotoxicity
2007:45:102-110
$5:62 2007:45:391-403
ilton TP Destro A (see Di Tommaso L et al). 2007
1118 $5:725-734 10 E (see Hoofnagle JH et al). 2007:45
ce Plentz RR et al). 2007;45:968-976 1056-1075 (Review
inne © wre GI. | nhancing hepatitis C treatment
Destro 19¢ 3.77e9e FasolatSo e t al). 2007;45 uptake and outcomes for injection
Deutz NEP (see Olde Damink SWM lrug users. 2007;45:3-5 (Editorial
ind Micallef J. Low incidence of HC\
2007:45:560-568
\ and Cederbaum AI. Induction of reinfection: Exposure, testing
cytochrome promotes liver injury in frequency or protective immunity
2007;45:13 Correspor
ob/ob mice. 2007:45:1355 465
Dharancy S ¢ Louvet Ae t al). 2007 nou B ) +5 95 /
967
1348-1354
Yrexhage JAR (see Rollier | 007
Dhiman RK (see Prasad Se t al). 2007
549-559 +5:602-613
Drummer H
Di Bisceglie AM. The AASLD and public
1-920
policy: Coming in out of the cold
nont ]M
1007:45:1335-1336 (AASLD Publi
928
Policy
Di Martino \ Chévenot T et al). 2007 982-997ee Keane MH et al). 2007:45
$5:377-383
Durazzo M (see Gambino R et al). 2007
Di Tommaso L, Franchi G, Park YN
+5:1097-1100
Fiamengo B, Destro A, Morenghi I
Duseja A (see PrasaSd e t a 200
Montorsi M, Torzilli G, Tommasini
55S9
M, Terracciano L, Tornillo |
Duverger B (see Rollier CSe t
Stefano\ Vecchione R, Roncalli M. Diagnostic
602-613
ChiusoloP , Sica S Leone G value of HSP70, glypican 3, and
'
prev ilence of the JAK2 Vol7!I glutamine synthetase in hepatocellular
mutation in patiwiteh enxtrtahespat ic noduinl cierrhsosi s. 2007;45:725-73 E
portal vein thrombosis. 2007:45:831 Diaz E (see Louvet Ae t al). 2007;45:1348
832 (Correspondenc« 1354 Earnest-Silveira| lorresi | et al). 2007
Deaciuc I (see McClain C]e t al). 2007:45 Diehl AM (see JungY et al). 2007;45 #5:911-920
1343-1346 (Editorial 1091-1096 (Rapid Communication Edwards R (see Visvanathan K et al). 2007
Dedhar S (see Gkretsi V et al). 2007:45 ee Yamaguchi K et al). 2007;45:1366 +5:102-110
1025-1034 | + El-Badry AM, Moritz W, Contaldo¢
Dejana E (see Bordoni V et al). 2007 Dienes H (see MinukG Y et al). 2007:45 lian Y, Graf R, Clavien PA
1218-1228 52 +5 Prevention of reperfusion injury and
HEPATOLOGY AUTHOR INDEX
microcirculatory failure in Feitelson MA (see Lian Z et al). 2007:45 protease quasispecies. 2007;45:899
macrosteatotic mouse liver by omega 1390-1399 910
3 tatty acids. 2007:45:855-863 Feld 1] see Hussain N et al) 2007:45:675 rasson I (see Fasolato S et al). 2007:45
I lvevold EH (see Malovi« I et al 2007:45 683 223-229
1454-1461 elip V (see Romero-Gémez M et al rémin C, Ezan F, Boisselier P, Bessard A
nders F (see AnguPl eot al). 2007:45:846 2007:45:879-885 Pages G, Pouysségur J, Baffet G
854
engQ (seé Xu J et al). 2007:45:269-276 ERK2 but not ERK] playsa key rok
ndou H (see Shin H] et al). 2007 engS (see Sekine Se t al). 2007;45:361 in hepatocyte replication: An RNAi
1046-1055 368 mediated ERK2 knockdown approach
nomoto A (see Shin H] et al). 2007 erdinandusse S (see Keane MH et al) in wild-type and ERK] null
1046-1055 2007 :45:982-997 hepatocytes 2007:45:1035-1045
nomoto K (see Ito A et al). 2007:45:684 ernandez V, Castillo 1, TapiaG riedman JE (see Rahman SM et al). 200
694 Romanque P, Uribe-Echevarria S$ +5:1108-1117
rhardt A, Biburger M, Papadopoulos 1 riedman S (see Wurmbach E eta l). 200
Uribe M, Cartier- garte D
Tiegs G IL-10 regulatory I cells, Santander G, Vial MT, Videla LA $5:938-947
and Kupffer cells mediate tolerance rhyroid hormone preconditioning riedman SL, Rockey DC, Bissell DM
concanavalin A-induced liver injury Hepatic Fibrosis 2006: Report of the
P rotectti on against iscIh emia
mice. 2007;45:47 rhird AASLD Single lopic
reperfusion liver injury in the rat
rnst M (see YeohG ‘ Conference. 2007;45:242-249
2007;45:170-1
4860-494 AASLD Single Topic Conference
ernandez-Martinez A (see Casado M et al
rofeev AV riis SL (see Jelnes Pe t al). 2007;45:1462
2007:45:631-638
1454-146] 170
temadian A (see Bajaj JS et al). 2007:45 errari C 58(se e 2)L 5u9 kas(iCeorwriecszp Eo ndete ncal)e. ) 2007 u H (see Loomes KM et al). 2007;45:323
833-834 (¢ orrespondence 450
ee Penna Ae t al). 2007;45:588-601
verhart | ee ConjeevarHaS me t al ujil [ (see Zen Y et al). 2007:45:1538
2007:45:80-87 errari ( ee Westin |). 2007:45:1333 1546
verson GT. Impact of disease severity on 1334 (Correspondence Fujimoto Y (see Hatakeyama T et al). 200
outcome of antiviral therapy in erraz MLG SchiavonL L eta l 2007 +5:1179-1186
treatment-naive patients with chronic $5:257-258 (Cx rrespondence uruya MH (see Neuyen LN et al). 2007
hepatitis ( 2007;45:1334 (Reply esti D see Colecchia A and Festi D +5:31-4]1
vert M (see Dombrowski F and Evert M 2007:45:259-260 (¢ orrespondence
2007 iamengo B (see Di Tommaso L et al
2007:45:1035 2007 G
1045 2007:45:968-976
acta GB (see BrunSo e t al). 2007;45:579
iel I (see Wurmbach E et al). 2007:45
938-94 587
iorini A (see De Stetano V et al). 2007:45 alhenage S (see Jeffrey GP et al). 2007:45
111-117
831-832 (Cort spondence
cher AE (see Torresi | et al). 2007 illin JI (see Hussain N et al). 2007
911-920 6/5-6835
illusS (see Parente F et al). 2007;45
viaM (see Romero-GoémMe ze t al
832-8e3e 3 Pri(mRiepgln a 2007-45:879-885 ilman C 12(s7e4e Cast|r eto a l). 2007:45
| , Hootnagle JH et al). 2007
wiuoli S (see Brun 1075 (Review 261-1266
58 alun | ee Ben Moshe T eta 2007:45
ontaine H MalmassariS L et 2007
FasolatoS et al 1014-1024
=
wrouch Z Lollier ¢ umbino R, Cassader M, Pagano G
Lindsay KI
Durazzo M, MussoG . Polymorphism
ra it EC, Snow
in microsomal triglyceride transfer
KK, Lok ASF, Krontol Z
protein: A link berween liver disease
Padmanabhan L, HALT-C Tria
Group. Cognitive functiodno es not und itherogeni« postpr indial lipid
profile in NASH? 2007;45:1097-110
worsen during pegylated inter! eron
ngulo P et il 200 indhi ¢ ee ZenGg e t al). 2007;45:195
ind ribavirin retreatment of chronic 04
hepatitis C. 2007:45:1154
2007 unten IM (see Koschny Re t al). 200
1348 1 oschi M é Vizzurti | et il +5:649-658
isolato S, Angeli P, Dallagnese L, Maresio urcia-Eulate R (see Hussain N et al
G, Zola E, Mazza | Salinas | Dona 2007:45:675-683
SI igiuoli S, Sticca A, ZanusG , Cillo urnier D (see Cerec V et al). 2007;45
[ Frasson I, Destro C, Gatta A ox I] (see Mashalova EV et al). 2007:45 957-967
Renal failure and bacterial infectior 755-766 atsios P (see Keitel V et al). 2007;45:695
in patients with < irrhosis ranchiG (see Di Tommaso L et al). 200 704
Epidemiology and clinical features 45:725-734 atta A (see FasolatSo e t al). 2007;45:2
2007 ;45:223-229 rancoD (see Boyault S et al). 2007;45:42 99
Faust PL (see Keane MH et al). 2007:45 5? ault E (see Le Gal F et al). 2007;45:1
987-997 ranco S, Parera M, Aparicio E, Clotet B 1333 (Reply)
Fausto N (see Neuven LN et al). 2007:45 Martinez MA. Genetic and catalytic Ge S (see Rountree CB et al). 2007;45
31-41 efhciency structure of an HC\ 1250-1260
THOR | NDEX HEPATOLOGY, June 2007
(,sednar dt R (see We Sinclair JF, Sinclair PR Eftect of iron H
1083 (Reply
ind ascorbate on uroporphyria in
Geier A ind I rautw iscorbate-requiring mice as 1 model Haas Tl see Koschny R et al). 2007;45
ymecou for porphyria cutanea tarda. 2007;45 649-658
n Habersetzer F (see Nousbaum JB et al
ful ction 187-194
2007;45:1275-1281
gulsalatre ;orrell MD and Warner F] Foolintgh e
reHgee panteroaltoigoyn / liHveer:p atMoalloagryi a Eilnsceowghneirteo . 200 +5:826 Hadzi3y07a-n3n] isS3 ] (see Rapti | et al). 2007;45
srace ND and Dennis LB. Advocacy Hafeezullah M ce Bajaj JS et al). 2007:45
What is a nice scientist like you doing 833-834 (¢ orrespondence
Hagege H (see Thévenot T et al 2007:45
sCOTLie in Washington, DC? 2007;45:1337
377-383
46 %) 1339 (AASLD Public Policy
Hak voort TBM, VermeuleJnLM , Lamers
Graf R (see El-Badry AM et al 2007-45
WH STATS deficiency does not
855-863
iffect the « xpression of glutamine
ee Nocito Ae t al 2007:45 369-376 synthetase in mouse liver 2007:45
srail D (see Yeoh GC T et al 2007-45 1082 (¢ orrespondence
659-0605 4186-494 e Stanulovic VS et al 2007 :45:433
2007 :45 srangeé JD (se Nousbaum 1B eral 200 144
$5:1275 1281 HAL T-( [rial Group ee FontanRJa e t
srattagliano I, Portincasa P Palmieri VO il). 2007;45:1154-1
PalascianoG Mutual change ot Han BH (see Yoo BC «
thioredoxin and nitrosothiols during 1178
biliary cirrhosis Results from humans Han JY (see Yoo BC et al
ind cholestatic rats 2007:45:3 1178
irebely |, Conway B, Rafta JD, Lai ¢ Handem | (see Mayo M] et
Krajden M, Tyndall MW Low 666-674
incidence of HC\ reinfection Hansen BE (see
| x posure testing frequency #5:258-259 (Correspondence
protective immunity? 2007 Harada H (see Nakamura M et al
$5:118-12
Harada K 2007
1546
vomes KM et al 2007 Harada M, Strnad P, Resurreccion EZ, Ku
NO, Omary MB. Keratin
iTipor 2007:45:95 overexpression but n
phosphorylation or filament
OG 7
rrollo | 2007 organization blocks mouse Mallory
970 bod formation. 2007:45:88-96
Moshe 1 00 WrighGt e t al). 2007:45
»007
Lim JK and Groszmann
i88
5:1087 1090 (Editorial
ee Yovche MI et al Hasuitke Ss €t Kanmura S et 2007-45
948-956
200
suan tz | Werth M et al 00 HatakMeoyraim a N, I, TsNugoeg ucM,h i I¢m amHuirr agia M ‘\
1083 (Reply
Takahashi S$, Kawakami I ujyimoto
n-Guillouzo ¢ Y, Ochi H, Abe H, Maekawa |
2007-45-95 967 Kawakami H, Yatsuji H, Aisaka ¥
Kohno H, Aimitsu S$, Chayama K
Serum HBV RNA is a predictor of
ind Guido M
early emergence of the YMDD
(Correspondenc mutant in patients treated with
Lévesque I eta 200 umivudine. 2007;45:1179 1186
soodmial! ZD, | Haussinger D (see Keitel V et il). 2007;45
|NH Guill-o uH ‘ (see MartPiGPn e t al). 2007 695-704
hr oO nic f Hay ashi H and Sugiyama Y. 4
morp! 1OmM« suo L (see Gkretsi V et al). 2007 Phenylbutyrate enhances the cel
RR 6-5 1034 surface expression and the transport
007 suo Y ce 4 ui | t al). 2007:45 capacit ot wild type ind mutated bile
suptaS ee Yovchev M1 et al salt export pumps 2007:45:1506
139 149 1516
sura KM ce Lee S et al 201 Hayashi K (see Kanmura S et al 2007:45
845 Editorial 948-956
(sorman N Zaharia \ l rask HS »zakacs Gutiérrez PJA (see Sekine Se t al Hayashi N (see Tatsumi T et al). 2007;45
IG Jacobs N] Jacob |M BalestraD 461 308
HEPATOLOGY, Vol. 45, No. 6, 200 AUTHOR INDEX Vil
Hayashi S (see Nakamura M et al). 2007 acids in man. 2007;45:1083-1084
45:118-127 (Correspondence
HayesP ¢ see Olde Damink SWM). 2007; Holdren MS (see Nguyen LN et al). 2007 Ichijo T (see Yokosawa S et al). 2007:45
45:560-568 $5:31-4] 384-390
He W (see Ng TI et al). 2007;45:1413 Holland SM (see Hussain N et al). 2007; Ido A (see Kanmura S et al). 2007:45:948
1421 45:675-683 956
see Shin H] et al). 2007;45:1046 Hollebecque A (see Louvet A et al). 2007 leraci A (see Moumen Ae t al). 2007:45
1055 +5:1348-1354 1210-1217
He Y (see Ne Tle t al). 2007;45:14 Holtmann B (see Marqués JM et al). 2007 Ignee A( see Dietrich CF et al). 2007;45
Hebrok M (see Sekine S et al). 2007 +5:639-648 1139-1145
361-368 Holz LE (see Bertolino P and Holz LI Imamura M (see Hatakeyama T et al
Heeney JL (see Rollier CS et al). 2007:45 2007:45:250-251 (Hepatology 2007;45:1179-1186
Imperiale TF, Klein RW, Chalasani N
602-613
Heidrich B (see Wedemeyer H et al). 2007; HondaI isK€u h(ese e re Nakamura M et al). 2007;45 Cost-ettectiveness analysis of variceal
45:1331-1332 (Correspondence) 118-127 ligation vs. beta-blockers for primary
Heller J (see Hennenberg M et al). 2007 Hong YY (see Higashiyama R et al). 2007; p4r5e:v8e7n0t-i8on7 8 of variceal bleeding.; 2007
45:495-506 45:213-222
Inagaki Y (see Higashiyama R et al). 2007;
Heller T (see Hussain N et al). 2007:45 Hooftnagle JH, Doo | Liang TJ, Fleischer
$5:213-222
675-683 R, Lok ASF. Managemento f hepatitis
Hellstrand K (see Lukasiewicz E et al inchauspe G (see Rollier CS et al). 2007
B: Summary of a clinical research +5:602-613
2007;45:258-259 (Correspondence
workshop 2007:45:1056-1075 Inoue K, Umehara T, Ruegg UT, Yasui F,
(seCe orWersetsipn on]d)e.n 2c0«0 7:45:1333-1334 Review Watanabe T, Yasuda H, Dumont JM
(see Conjeevaram HS et al). 2007;45 Scalfaro P, Yoshiba M, Kohara M
Hennenberg M, Trebicka J, Biecker I 80-8 Evaluation of a cyclophilin inhibitor
Schepke M, Sauerbruch T, Heller J
see Hussain N et al). 2007;45:675-683 in hepatitis C virus-infected chimeric
Vascular dysfunction in human and
Hoogenkamp M (see Stanulovic VS et al mice in vivo. 2007;45:921-928
rat cirrhosis: Role of receptor
desensitizing and calcium-sensitizing 2007;45:433-444 Inoue Y (see Reddy AB et al). 2007:45
Horwitz MS (see Mashalova EV et al 1478-1488
proteins 2007 :45:495-506
2007:45 755-766 Invernizzi P (see Oertelt S et al). 2007;45
Hérault A (see Boyault S et al). 2007:45:42
Houitte D ee Malmassari SL et al). 2007 659-665
py 45:1199-1209 Iredale J (see Lee JS). 2007;45:817-825
Hernandez-Zavala A (see Straub AC et al
2007 :45:205-212 Huang] (see Yamaguchi K et al). 2007;45 Review
1366-1374 Ishibashi H (see Nakamura M et al). 2007
Heuckeroth RO WanHg e t al). 2007
Huang KW (see Chang C] et al). 2007;45 +5:118-127
#5:1527-1537
40-/94 Ishida Y (see Kanmura S et al). 2007:45
Higashiyama R, Inagaki \ Hong Y)
Kushida M, Nakao S, Niioka M Hudson M (see Newton JL et al). 2007:45 948-956
Watanabe T, Okano H, Matsuzaki \ 1496-1505 Ito \ Nishikawa Y Ohnuma K Ohnuma
Hui JM Anguk I, Koma Y, Sato A, Enomoto K,
dSheiortai Gce,l vlOsk eaezxdparke iss I.m aBtorniex marrow 854 lsujimura T, Yokozaki H. SgIGSF is
metalloproteinases and contribute to HuiP (see Yeo XW $5:1382 a novel biliary-epithelial cell adhesion
1389 molecule mediating duct/ductule
regression of liver fibrosis in mic« Hulse G (see Jettre GP et al). 2007:45 development. 2007;45:684-694
2007:45:213-222 111-11 Ito M (see Nakamura M et al). 2007;45
Hillig6os7s5 -6LD8 3 (see Hussain N al). 2007:45 Hunt SP, Kivama H, Smith AJH, Laurence Iwasaki1 18S- 12( see Hirose Ae t al). 2007;45
Himou6d0i2 -6N1 3 (see Rollier CS et al). 2007:45 Ct. argWehteidc h thagte ne,a fteRcteedg 2loi vrer Reg3B, was 1375-1381
Hiraga N (see Hatakeyama T et al). 2007 neration? 2007:45:1585-1586
+5:1179-1186
eld JJ, Kleiner DE, Hoofnagl
Hirose A, Ono M, Saibara T, Nozaki ¥ Jackson D¢ e Torresi | et al). 2007:45
1H, Garcia-Eulate R, Ahlawat S
Masuda K Yoshioka \ | ikahashi M 911-920
Koziel DE, Anderson V, Hilligoss D
Akisawa N, Iwasaki 8, Oben JA Jacobe H (see Mayo M] et al). 2007:45
Onishi S. Angiotensin I] type | Choyke P, Gallin JI Liang 1] 600-0/4
receptor blocker inhibits fibrosis in Malech HL, HollandSM , Heller 1 Jacobs JM (see Gorman N et al). 2007;45
nonalcoholic steatohepatitis. 2007 Hepatic ibnormalities in patients with 187-194
1375-1381 chronic granulomatous disease. 2007 JacobsN ] (see Gorman N et al). 200
Hissar S (see Kumar M et al). 2007:45:97 4$5:675-683 187-194
101 Hwang JS (see Yoo BC et al). 2007;45 Jaeschke H and Liu J. Neutrophil depletion
Ho WM (see Yeo W et al). 2007 45:1382 1172-1178 protects against murine
1489 Hwang LH (see Chang C] et al). 2007;45 acetaminophen hepatotoxicity
HodgesS ] (see Mookerjee RP et al). 2007 746-754 Another perspective. 2007;45:1588
45:62-71 HwangSG (see Yoo BC et al). 2007;45 1589 (Correspondence)
1172-1178
see WrighGt e t al). 2007;45:151 (see Mookerjee RP et al). 2007:45:62
15 26 HynanLS (see Parekh NK et al). 2007;45 Jalan R (see Olde Damink SWM). 2007;
Hofmann AF. Why bile acid 1489-1495 45:560-568
glucuronidation is a minor pathway Hynd P (see Olde Damink SWM). 2007; (see WrigGht e t al). 2007;45:1517
for conjugation of endogenous bile +5:560-568 1526
AUTHOR INDEX HEPATOLOGY June 2007
Jalil R | see (Lastro ] et al 2007:4 Ss 261 Kallman J (see Younossi Z et al). 2007;45 Khouri D (see Bordoni V et al). 2007:45
1266 806-816 1218-1228
Jansen PLM ee Pellicoro A et al 2007 Kamath PS and Kim WR. The Model for Kikutani H (see Watanabe N et al). 2007
$5:340-348 End-stage Liver Disease (MELD). 45:1240-1249
Janssen R¢ ee Rahman SM et al 2007 2007:45:797-805 (Review) Kim BI (see Yoo B« et al). 2007:45:1172-
45:1108 |i 117 Kanai Y (see Shin H] et al). 2007;45:1046 1178
Jeannot E (see Boyault S et al). 2007;45:42 1055 Kim DG (see Yoo BC et al). 2007;45:1172-
Ss? Kang JX (see Schmiécker C et al) 2007:45 1178
letters I (S€€ Pockros P] et al 2007:45 864-869 Kim DK see Shin H] et al). 2007;45:1046-
569-578 Kang TB (see Ben Moshe T et al). 2007;45 1055
Jeffrey GP, MacQuillan G, Chua | 1014-1024 Kim H see Plentz RR et al). 2007;45:968-
Galhenage S, Bull J, Young I Hulse Kanmura S, Uto H, Kusumoto K, Ishida 976
G, O'NeilG . Hepatitis C virus Y, Hasuike S, Nagata K, Hayashi K Kim HC (see Yoo BC et al 2007;45:1172-
er adication in intravenous drug users Ido A, Stuver SO, Tsubouchi H 178
maintained with subcutaneous Early diagnostic potential for Kim JC (see Ben Moshe T et al 2007;45:
naltrexone implants 2007;45:111 hepatocellular carcinoma using the 1014-1024
117 SELDI ProteinChip system. 2007;45 Kim JH (see Yoo BC et al 2007;45:1172-
Jelnes P, Santoni-Rugiu | Rasmussen M 948-956 1178
FBriisigs aaSrId NHCi.e lseRn emJaHr,k Tabylges trup N Kao J1H1 98(s ee Lin CL et al) 2007;45:1193 Kim 1T1H7 8 see Yoo BC et al). 2007;45:1172
heterogeneity displayed by oval cell| s see Su I H et al) 2007:45 Kim WR (see Kamath PS and Kim WR)
in rat and mouse models of stem cell (¢ orrespondence) 2007:45:797-805 (Review)
mediated layer regeneration. 2007:45 Kaplowitz N (see Liu ZX and Kaplowitz
Kim YS (see Yoo BC et al). 2007;45:1172
1462-1470 N). 2007;45:1589 (Reply)
Jeong SH see Yoo BC eral 2007 45 Karp NA (see Reddy AB et al). 2007;45 1178
Kincaid J (see Younossi Z et al) 2007:45
1172-1178 1478-1488
806-816
Jiang H ee Rahman SM et il). 2007-45 Kato H (see Sugiyama M et al 2007-45
1108 1117 979.937 King J and Kowdley KV Pioglitazone for
JiangJ L (see Xu J et al 20 )7-4$95::22 69 276 Katsuyama Y ee Yokosawa § et al). 2007 patients with type 2 diabetes and
Jochum W (see Nocito A et 1). 2007:45 45:384-390 nonalcoholic steatohepatitis. 2007;45
827-829 (Hepatology Elsewhere
369-376 Katz SC (see Kingham TP et al) 2007;45
John B, Klein I, Crispe IN I mmune role, of 145-454 King \ M (SCE Reddy AB et al ° 2007:45
hmeopuastei c liveTrL R-4t ranrsepvleaanltea tdi obny. or2t0h0o7t;o4p5ic Kawa S \S€€ Yokosawa S et al . 2007-45 Kingh1a4m7 8-T1P4,88 Chaudhry UI, PlitasG , Katz
384 390
178-186 Kawakami H (see Hatakeyama T et al SC, Raab J], DeMatteo RP {urine
Johnstone D (see Milward I et al 2007 2007;45:1179-1186 liver plasmacytoid dendritic cells
45:253-256 Hepatology Elsewhere Kawakami M (see Koda M et al 2007:45 become potent immunostimulatory
835 (Correction IQ7 306 cells after Flt-3 ligand expression
Jones DE] (see Newton JI et al 2007:45 Kawakami Y (see Hatakeyama T et al 2007;45:445 454
1496-1505 2007;45:1179-1186 Kirby JA see Robertson H et al). 2007:45:
ee Robertson H et al 2007 5:97 Kawano M (see Zen Y et al 2007-45 977-981
98] 1538-1546 Kirschner ] ee Lebrecht D et al). 2007;45
Jose ph B ee Yovchev MI « tal > 007:45 Keane MH Overmars H, Wikander TM 72-79
139 149 Ferdinandusse S Duran M, Wanders Kishimoto Y €e Kod: M et al). 2007;45
Jouannaud \ €e Nousbau m |B« t RJA, Faust PI Bile acid treatment 297-306
2007:45 75 1281 alters hepatic disease and bile acid Kiyama H (see Hunt SP et a 2007:45
Journault K
transport in peroxisome-deficient 1585-1586 Rep y
128-138 PEX2 Zellweger mice. 2007:45:982 Kiyosawa K (see Yokosawa S et al 2007
Jover R (see Romero-Géme Zz M et 997 $5:384 390
2007 :45:879-885 Keitel V, Reinehr R, Gatsios P, Rupprecht Klei LR (see Straub AC et al). 2007:45
Ju C (see Yin H et al 2007-45 C, Gérg B, Selbach O, Haussinger D 205-212
Jun Sun P €e Lalor PI et il). 200 Kubitz R. The G-protein coupled bile Klein I (see John B et al) 2007:45:178-186
465-474
salt receptor TGRS is expressed in Klein RW (see Imperiale TF et al 2007:
Jung Y McCall S] Li YX Dieh AM. Bile liver sinusoidal endothelial cells 45:870-878
ductules and stromal « ells express
2007:45:695-704 Kleiner DE (see Conjeevaram HS et al
hedgehog ligands ind/or hedgehog Kench ] see AngulPo e t al). 2007:45:846 2007 ;45:80-87
target genes in primary biliary 854 see Hussain N et al). 2007;45:675-683
cirrhosis. 2007;45:1091-1096 (Rapid
Kew M (see Lian Z et al) 2007:45:1390 Knight B (see Nguyen LN et al). 2007;45
(Communication
1399 31-41
Kew M (see Minuk GY et al) 2007:45 Kobayashi M (see Nakamura M et al)
735-745 2007;45:118-127
K Khac EN (see Nousbaum JB et al). 2007 Koda M, Matunaga Y, Kawakami M,
+5:1275-1281 Kishimoto Y, Suou T, Murawaki Y.
Kaestner KH see Loomes KM et al 2007: Khatkar S (see Aborsangaya KB et al) Fibrolndex, a practical index for
$5:323-330 2007;45:623-630 predicting significant fibrosis in
Kahlke I Jee Schméc ker ( et al 2007:45 Khitrov G (see Wurmbach E et al). 2007 patients with chronic hepatitis
864-8609 45:938-947 2007;45:297-306
HEPATOLOGY, Vol. 45, No. 6, 2007 AUTHOR INDEX IX
Koev G (see Ng TI et al). 2007;45:1413 Hissar S, Pande C, Sharma BC, Sarin Lasserre F (see Martin PGP et al). 2007;45:
421 SK. A randomized controlled trial of 567.777
Koga M (see Nakamura M et al). 2007;45: lamivudine to treat acute hepatitis B. Latchoumycandane C, Goh CW, ¢ Ing
118-127 2007:45:97-101 MMkK, Boelsterli UA. Mitochondrial
Koh J (see Yeo W et al). 2007;45:1382- Kurtovic ] (see Visvanathan K et al). 2007; protection by the JNK inhibitor
1389 45:102-110 leflunomide rescues mice from
Kohara M (see Inoue K et al). 2007;45 Kushida M (see Higashiyama R et al). acetaminophen-induced liver injury
921-928 2007;45:213-222 2007;45:412-421
Kohga K (see Tatsumi T et al). 2007;45:22 Kusumoto K (see Kanmura S et al). 2007; Latendresse JR (see Donthamsetty S et al)
30 45:948-956 2007;45:391-403
Kohno H (see Hatakeyama T et al). 2007; Kweon YO (see Yoo BC et al). 2007:45: Laurence C (see Hunt SP et al). 2007:45:
45:1179-1186 1172-1178 1585-1586 (Reply)
Kolb A (see Koschny R et al). 2007;45:649 Kyriacou CP (see Reddy AB et al). 2007; Laurent-Puig P (see Boyault S et al). 2007:
658 45:1478-1488 (5:42-52 .
Koma Y (see Ito Ae t al). 2007;45:684-694 Kyrmizi I (see Stanulovic VS et al). 2007; Le Gal F, Castelneau C, Gault E, al
Komatsu T (see Nakamura M et al). 2007; 45:433-444 Hawajri N, Gordien E, Marcellin P,
45:118-127 Dény P. Hepatitis D virus infection
Komori A (see Nakamura M et al). 2007; Not a vanishing disease in Europe!
45:118-127 2007;45:1332-1333 (Reply)
L
Komurian-Pradel F (see Rollier CS et al Lebrecht D, Vargas-Infante YA, Setzer B,
2007;45:602-613 Kirschner ], Walker UA. Uridine
ath G (see Vizzutti F et al). 2007:45:1290-
Kondo H (see Nakamura M et al). 2007; supplementation antagonizes
1297
$5:118-127 agging M (see Lukasiewicz E et al). 2007; zalcitabine-induced microvesicular
Koschny R, Ganten TM, Sykora J, Haas 45:258-259 (Correspondence) steatohepatitis in mice. 2007;45:72
lL, Sprick MR, Kolb A, Stremme 79
(see Westin ]). 2007:45:1333-1334
W, Walczak H. TRAIL/bortezomib (¢ orrespondence) Lechel A (see Plentz RR et al). 2007;45:
cotreatment is potentially hepatotoxic aguna JC (see Roglans N et al). 2007;45: 968-976
but induces cancer-specific apoptosis 778-788 Lee H] (see Yoo BC et al). 2007;45:1172
within a therapeutic window. 2007; ai C (see Grebely J et al). 2007;45:1331 1178
45:649-658 (Reply) Lee HS (see Yoo BC et al). 2007;45:1172
Kovalenko A( see Ben Moshe T et al) ai MY (see Lin CL et al). 2007;45:1193 1178
2007;45:1014-1024 1198 Lee HY (see Yoo BC et al). 2007;45:1172
Kowdley K, McCaughan G, Trautwein ( alor PF, Jun Sun P, Weston CJ, Martin 1178
Hepatology Elsewhere. 2007;45:250 Santos A, Wakelam MJO, Adams Lee JMF (see Wong CM et al). 2007:45:
256, 540-544, 826-830, 1076-1081 DH. Activation of vascular adhesion 1129-1138
1324-1329, 1578-1582 protein-1 on liver endothelium results Lee JS, Semka D, Iredale |, Shah VH
Kowdley KV. Alcohol intake and iron in an NF-«KB-dependent increase in Sinusoidal remodeling and
overload: Another role for hepcidin lymphocyte adhesion. 2007;45:465 angiogenesis: A new function for the
2007;45:541-543 (Hepatology 474 liver-specific pericyte? 2007;45:817
Elsewhere) am KC (see Yeo W et al). 2007;45:1382 825 (Review)
see King J] and Kowdley KV). 2007;45 1389 LeKSe ( see Yoo BC et al). 2007:45:1172
827-829 (He patology Elsewhere) am WY (see Yeo W et al). 2007;45:1382 1178
Koyabu M (see Nakamura M et al). 2007; 1389 Lee MS (see Yoo BC et al). 2007;45:1172
45:118-127 amers WH (see Hakvoort TBM et al 1178
Koziel DE (see Hussain N et al). 2007345 2007;45:1082 (¢ orrespondenc« ) Lee S, Gura KM, Puder M. Omega-3 fatty
675-683 (see Stanulovic VS et al). 2007:45:433 acids and liver disease. 2007;45:84 1
Koziel M] (see Sherman KE et al). 2007;45: 144 845 (Editorial)
1566-1577 (Special Articl an A (see Martin PGP et al). 2007;45 Lee WM (see Parekh NK et al). 2007;45
Krajden M (see Grebely J et al). 2007;45: 567.777 1489-1495
1331 (Reply an BYA (see Sekine S et al). 2007;45:361 Lee WS and Sokol RJ. Mitochondrial
Kremsdorf D (see Cerec V et al). 2007;45 368 hepatopathies: Advances in genetics
957-967 an RY (see Moritoki Y et al). 2007;45 and pathogenesis 2007;45:1555
Krishnan P (see Ng TI et al). 2007;45 314-322 1565 (Review)
1413-1421 ang T (see Schneider G et al). 2007;45 Lee Y] (see Yoo BC et al). 2007;45:1172
Kronfol Z (see Fontana RJ et al). 2007:45 150-158 1178
1154-1163 angenbach R (see Yin H et al). 2007;45 Lee YS (see Yoo BC et al). 2007;45:1172
Kruithof-de Julio M (see Stanulovic VS et : 159-169 1178
al). 2007;45:433-444 angkopf BHE (see Plentz RR et al). 2007; Legrand P (see Martin PGP et al). 2007;45
467.777
Ku NO (see Harada M et al). 2007;45:88 +5:968-976
96 anzoni VP (see Schiavon LL et al). 2007 Lei HY (see Chang CP et al). 2007;45:286
Kubitz R (see Keitel V et al). 2007;45:695 45:257-258 (Correspondence 296
704 arrea E (see Rollier CSe t al). 2007;45 Leiper ] (see Mookerjee RP et al). 2007;45
Kullak-Ublick GA (see Schneider G et al) 602-613 62-71
2007;45:150-158 arsen FS (see Schmidt LE and Larsen FS). Leistikow R (see Wertheimer AM et al)
Kumanogoh A (see Watanabe N et al) 2007;45:789-796 2007;45:1422-1432
2007;45:1240-1249 asarte || (see Rollier CS et al). 2007;45: Lenzi M (see Angulo P et al). 2007;45:846
Kumar M, Satapathy S, Monga R, Das K, 602-613 854
AUTHOR INDEX HEPATOLOGY, June 2007
Leone G (see De Stetano V et al). 2007;45 Lin YS (see ¢ hang ( P et al). 2007:45:286 Ramond MJ], Diaz E, Fartoux |
831-832 ( orrespondenc: 296 Dharancy S, Texier I Hollebecque A
Lépine J (see Lévesque E et al). 2007;45 Lindor K (see Angulo P et al). 2007;45 Sertaty L, Boleslawski E, Deltenre P,
128-138 846-854 Canva V, Pruvot FR, Mathurin P
Leung NWY (see Yeo W et al). 2007;45 (see Bjérnsson E et al). 2007;45:1547 The Lille model: A new tool for
1382-1389 1554 (Review) therapeutic strategy in patients with
Leung PSC (see Oecrtelt S et al). 2007;45 Lindor KD. HEPATOLOGY’s Newest Team severe alcoholic hepatitis treated with
OXV-Ob 2007;45:1-2 (Editor's Corner steroids. 2007;45:1348-1354
Lévesque E, Girard H, Journault K, Lépine Lindsay KL (see Fontana RJ et al). 2007;45 Lu SC (see Mato JM and Lu SC). 2007;45
J, Guillemette C. Regulation of the 1154-1163 1306-1312 (Review)
UGTIAI bilirubin-conjugating Lipschitz J (see Minuk GY et al). 2007;45 Lukasiewicz E, Hellstrand K, Westin J,
pathway: Role of a new splicing event 735-745 Ferrari C, Neumann AU, Schalm SW,
at the UGTIA locus. 2007;45:128 isa A (see Pollicino T et al). 2007:45 277 Zeuzem S, \ eldt BI, Hansen BI
285 Verhey-Hart E, Lagging M
138
iu C] (see Lin CL et al). 2007:45:1193 Predicting treatment outcome
evrero M (see Pollicino T et al). 2007:45
_ 1198 following 24 weeks peginterferon a
Z 285
Lewin S (see Visvanathan K et al). 2007:45 iu HS (see Chang CPe t al). 2007:45:286 2a/ribavirin therapy In patients
296 ; infected with HCV genotype |
102-110
iu | (see laeschke H and Liu J). 2007:45 Utility of HCV-RNA at day 0, day
i | (see Savransky V et al). 2007:45:1007
1588-1589 (Correspondence 22, day 29, and week 6. 2007;45:258
1O13
(see Lian Z et al). 2007:45:1390-1399 259 (Correspondence
i L (see Xu J et al). 2007;:45:269-276
i Y (see XuJ et al). 2007;45:269-276 iu JL and Cui W. Which gene, Reg2 or Lunel-Fabiani F (see Thévenot T et al
Reg3B, was targeted that affected liver 2007;45:377-383
i YX (see Jung Y et al). 2007;45:1091
1096 (Rapid Communication regeneration? 2007;45:1584-1585 Luo JH (see Paranjpe S et al). 2007;45
i YX (see Yamaguchi K et al). 2007 ( orrespondence) 1471-14
iu L (see Mashalova EV et al). 2007:45
1366-1374
ian Z, Liu J, Wu M, Wang HY 755-766
iu Y (see Cai J et al). 2007;45:1229-1239 M
Arbuthnot P, Kew M, Feitelson MA
iu ZX and Kaplowitz N. Neutrophil
Hepatitis B x antigen up-regulates Mackay IR (see Moritoki Y et al). 2007:45
depletion protects against murine
vascular endothelial growth f 314-322
acetaminophen hepatotoxicity
receptor 3 in hepatocarcin Maclean KN (see Rahman SM et al). 2007
Another perspective. 2007;45:1589
2007 :45:1390-1399 45:1108-1117
Reply ~
ian ZX (see Moritoki Y Llovet JM (see Wurmbach E et al). 2007 MacQuillan G see Jettrey GP et al). 200
314 5:111-11
$5:938-947 Maekawa T (see Hatakeyama 1
107 LobeckH (see Schmécker C et al). 2007 2007;45:1179-1186
+5:864-869 Maillere B (see Malmassari SI
Hu Sall Locarnini S (see VisvanathKa ne t al). 2007 45:1199-1209
Lok A+S)F 10a2n d 1M10c Mahon BJ. Chronic Maina 12| 10-1¢ 21M7o umen A et il 2007 +5
ce Bogdanos DP «
Corresponden heApAaStiLtDi s PBr. ac2t0i0ce7 ;4G5u:i5d0e7li-n5e3s9 Malaki‘ 5-M6 2-71(see Mookerjee RP et al). 2007
iaw YI cu thera py for lamivudine and McMahon BJ. Corrections to Malech HI e Hussain N et al). 2007:45
resistant chronic hepatitis B: Wher AASLD guidelionn cehrosni c 675-683
ind how?. 2007:45:266-268 hepatitis B. 2007;45:1347 (AASLD Malmassari SL, DengQ , Fontaine H
Editorial Practice Guideline
iaw YI ee Fontana R>J et al). 2’ 007;7 45:1111 54 H‘M oauililtetree DB,,? PRoilm lSi, ngMeirc heFl, TMLh.i ersIm \p act
5:118 1163 of hepatitis B virus basic core
iedtke C and Streetz KI 9 1007
ee Hootnagle JH et al). 2007;45:1056 promoter mutationso n T cell
from embryonic stem cells —< (Dp
1075 (Review response to an immunodominant
Prometheus revisited? 2007;45:829
Lonardo A, Loria P, Bertolotti M, Carulli HBx-derived epitope. 2007;45:1199
R30 Hepatology / vnere N. Statins and HCV: A complex 1209
illey KS (see Reddy AB et al). 2007;45 issue. 2007:45: 2a5e7 s (Correspondence Malovic |, Sorensen KK, Elvevold EH
1478-1488 LonSg (s ee YeohG CT et al). 2007;45:486 NedredalGI , Paulsen S, Erofeev AV
im JK and Groszmann RJ. Transient
194 Smedsrod BH, McCourt PAG. The
elastography for diagnosis of portal Loomes KM, Russo P, Ryan M, Nelson A
mannose receptor on murine liver
hypertension in liver cirrhosis: Is there Underkoffler L, Glover C, Fu H sinusoidal endothelial cells is the main
still a role for hepatic venous pressure Gridley T, Kaestner KH, Oakey RJ denatured collagen clearance receptor
gradient measurement? 2007;45 Bile duct proliferation in liver-specific 2007:45:1454-1461
1087-1090 (Editorial Jagl conditional knockout mice Mangelsdorf D] (see | ppal H et al). 2007
Lin CL, Liao LY, Liu CJ], Yu MW, Chen Effectso f gene dosage. 2007;45:323 $5:422-432
P], Lai MY, Chen DS, Kao JH 330 Mangia A (see Bruno S et al). 2007;45:579
Hepatitis B viral factors in HBeAg LoriaP (see Lonardo Ae ta l). 2007:45:257 58
negative carriers with persistently (Correspondence) Mangia A( see Pazienza V et al). 2007;45
normal serum alanine Louie SG (see Zheng Y et al). 2007:45:16 1164-1171
aminotransferase levels. 2007;45 21 Mani AR (see Wright G et al). 2007;45
1193-1198 Louvet A, Naveau S, Abdelnour M, 1517-1526